Inovio Pharmaceuticals
INO
INO
94 hedge funds and large institutions have $161M invested in Inovio Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 24 increasing their positions, 28 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
14% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 28
27% less call options, than puts
Call options by funds: $2.14M | Put options by funds: $2.93M
Holders
94
Holding in Top 10
1
Calls
$2.14M
Puts
$2.93M
Top Buyers
| 1 | +$16.1M | |
| 2 | +$8.7M | |
| 3 | +$5.19M | |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$2.4M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.74M |
Top Sellers
| 1 | -$2.68M | |
| 2 | -$2.47M | |
| 3 | -$1.6M | |
| 4 |
Goldman Sachs
New York
|
-$849K |
| 5 |
TCIM
TIAA CREF Investment Management
New York
|
-$755K |